These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10722517)

  • 1. Susceptibilities of oral and nasal isolates of Streptococcus mitis and Streptococcus oralis to macrolides and PCR detection of resistance genes.
    Ono T; Shiota S; Hirota K; Nemoto K; Tsuchiya T; Miyake Y
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1078-80. PubMed ID: 10722517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
    Tazumi A; Maeda Y; Goldsmith CE; Coulter WA; Mason C; Millar BC; McCalmont M; Rendall J; Elborn JS; Matsuda M; Moore JE
    J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis.
    Teng LJ; Hsueh PR; Chen YC; Ho SW; Luh KT
    J Antimicrob Chemother; 1998 Jun; 41(6):621-7. PubMed ID: 9687100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of macrolide resistance genes in clinical isolates of the Streptococcus anginosus ("S. milleri") group.
    Jacobs JA; van Baar GJ; London NH; Tjhie JH; Schouls LM; Stobberingh EE
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2375-7. PubMed ID: 11451701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of macrolide-resistant genes in group C and G streptococci].
    Seral C; González V; Castillo J; García C; Rubio MC; Gómez-Lus R
    Rev Esp Quimioter; 2000 Jun; 13(2):171-5. PubMed ID: 10918090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic susceptibility and prevalence of erythromycin ribosomal methylase gene, erm(B) in Streptococcus spp.
    Hung SW; Wang SL; Tu CY; Tsai YC; Chuang ST; Shieh MT; Liu PC; Wang WS
    Vet J; 2008 May; 176(2):197-204. PubMed ID: 17400007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of the tet(O) gene in erythromycin- and tetracycline-resistant strains of Streptococcus pyogenes and linkage with either the mef(A) or the erm(A) gene.
    Giovanetti E; Brenciani A; Lupidi R; Roberts MC; Varaldo PE
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2844-9. PubMed ID: 12936983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phenotypes and genetic mechanisms of resistance to macrolides and lincosamides in viridans group streptococci].
    Artiles Campelo F; Horcajada Herrera I; Alamo Antúnez I; Cãnas Pedrosa A; Lafarga Capuz B
    Rev Esp Quimioter; 2007 Sep; 20(3):317-22. PubMed ID: 18080028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of resistance to macrolides and lincosamides among staphylococci and streptococci from various animal sources collected in the resistance monitoring program BfT-GermVet.
    Lüthje P; Schwarz S
    Int J Antimicrob Agents; 2007 May; 29(5):528-35. PubMed ID: 17307339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolide resistance genes in Enterococcus spp.
    Portillo A; Ruiz-Larrea F; Zarazaga M; Alonso A; Martinez JL; Torres C
    Antimicrob Agents Chemother; 2000 Apr; 44(4):967-71. PubMed ID: 10722498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients.
    Wisplinghoff H; Reinert RR; Cornely O; Seifert H
    J Clin Microbiol; 1999 Jun; 37(6):1876-80. PubMed ID: 10325340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolone resistance in atypical pneumococci and oral streptococci: evidence of horizontal gene transfer of fluoroquinolone resistance determinants from Streptococcus pneumoniae.
    Ip M; Chau SS; Chi F; Tang J; Chan PK
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2690-700. PubMed ID: 17548487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relatedness among penicillin-binding protein 2b genes of Streptococcus mitis, Streptococcus oralis, and Streptococcus pneumoniae.
    Potgieter E; Chalkley LJ
    Microb Drug Resist; 1995; 1(1):35-42. PubMed ID: 9156382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of the erm(T) gene in clinical isolates of erythromycin-resistant group D Streptococcus and Enterococcus.
    DiPersio LP; DiPersio JR; Frey KC; Beach JA
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1567-9. PubMed ID: 18285483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viridans group streptococci: a reservoir of resistant bacteria in oral cavities.
    Bryskier A
    Clin Microbiol Infect; 2002 Feb; 8(2):65-9. PubMed ID: 11952717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Macrolide resistance phenotypes and genotypes in group G streptococci].
    Açikgöz ZC; Göçer S; Almayanlar E
    Mikrobiyol Bul; 2003; 37(2-3):117-24. PubMed ID: 14593892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors.
    Bemer-Melchior P; Juvin ME; Tassin S; Bryskier A; Schito GC; Drugeon HB
    Antimicrob Agents Chemother; 2000 Nov; 44(11):2999-3002. PubMed ID: 11036012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different erythromycin resistance mechanisms in group C and group G streptococci.
    Kataja J; Seppälä H; Skurnik M; Sarkkinen H; Huovinen P
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1493-4. PubMed ID: 9624500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species.
    Jalava J; Kataja J; Seppälä H; Huovinen P
    Antimicrob Agents Chemother; 2001 Mar; 45(3):789-93. PubMed ID: 11181362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.